111 related articles for article (PubMed ID: 16357456)
1. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid.
Yoshimoto T; Doi M; Fukai N; Izumiyama H; Wago T; Minami I; Uchimura I; Hirata Y
Intern Med; 2005 Nov; 44(11):1174-7. PubMed ID: 16357456
[TBL] [Abstract][Full Text] [Related]
2. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
3. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies.
Iwasaki H; Sato R; Shichiri M; Hirata Y
Endocr J; 2001 Apr; 48(2):261-8. PubMed ID: 11456277
[TBL] [Abstract][Full Text] [Related]
4. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.
Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z
Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535
[TBL] [Abstract][Full Text] [Related]
5. Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.
Ganelin-Cohen E; Modan-Moses D; Hemi R; Kanety H; Ben-Zeev B; Hampe CS
Pediatr Diabetes; 2016 Dec; 17(8):617-622. PubMed ID: 26711844
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
7. GAD-65 autoantibody associated epilepsy.
Dimova R; Grozeva G; Chakarova N; Tsarkova P; Tankova T
J Pediatr Endocrinol Metab; 2020 May; 33(6):817-820. PubMed ID: 32436860
[TBL] [Abstract][Full Text] [Related]
8. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
Prázný M; Skrha J; Límanová Z; Hilgertová J
Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
[TBL] [Abstract][Full Text] [Related]
11. [A case of progressive continuous muscular rigidity and painless and rhythmic muscle spasm associated with autoantibody against glutamic acid decarboxylase].
Oe H; Miyashita K; Tanaka K; Naritomi H; Kinugawa H; Sawada T
Rinsho Shinkeigaku; 1996 Oct; 36(10):1166-71. PubMed ID: 8997142
[TBL] [Abstract][Full Text] [Related]
12. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
Solimena M; Folli F; Denis-Donini S; Comi GC; Pozza G; De Camilli P; Vicari AM
N Engl J Med; 1988 Apr; 318(16):1012-20. PubMed ID: 3281011
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.
Peltola J; Kulmala P; Isojärvi J; Saiz A; Latvala K; Palmio J; Savola K; Knip M; Keränen T; Graus F
Neurology; 2000 Jul; 55(1):46-50. PubMed ID: 10891904
[TBL] [Abstract][Full Text] [Related]
15. [A case of progressive encephalomyelitis with rigidity and myoclonus associated with anti-GAD, anti-glycine receptor and anti-GM1 antibodies].
Koike Y; Suwabe T; Konno T; Umeda Y; Oyake M; Fujita N
Rinsho Shinkeigaku; 2015; 55(2):111-4. PubMed ID: 25746075
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].
Akaishi T; Jin K; Kato K; Itabashi H; Misu T; Tateyama M; Iwasaki M; Aoki M; Nakasato N
Rinsho Shinkeigaku; 2015; 55(11):804-9. PubMed ID: 26369378
[TBL] [Abstract][Full Text] [Related]
17. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol.
Papadimitriou DT; Marakaki C; Fretzayas A; Nicolaidou P; Papadimitriou A
J Diabetes; 2013 Sep; 5(3):344-8. PubMed ID: 23302101
[TBL] [Abstract][Full Text] [Related]
18. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody.
Cikrikçili U; Ulusoy C; Turan S; Yildiz S; Bilgiç B; Hanagasi H; Baykan B; Tüzün E; Gürvit H
Clin EEG Neurosci; 2013 Jul; 44(3):232-6. PubMed ID: 23820312
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
Georgieva Z; Parton M
BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
[TBL] [Abstract][Full Text] [Related]
20. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
Kataria R; Fernandes S; Lebastchi J; Bravo CA; Sena KN
Conn Med; 2017 Mar; 81(3):161-164. PubMed ID: 29772159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
